RedChip Companies
|
Weekly Newsletter
|
|
60 Degrees Pharmaceuticals Announces Closing of Initial Public Offering
|
60 Degrees Pharmaceuticals (Nasdaq: SXTP), specialists in developing and marketing medicines for infectious diseases, completed the closing of its initial public offering of 1,415,095 units (each, a “Unit,” collectively, the “Units”) at a price of $5.30 per Unit for a total of approximately $7.5 million of gross proceeds to the Company, prior to deducting underwriting discounts, commissions and offering expenses.
For more information, visit www.60degreespharma.com
|
BioVie to Present Data Showing How NE3107 Potentially Regulates DNA Methylation of Specific Genes in a Manner Highly Correlated to Observed Improvements in Cognition and Biomarkers of Disease
Biovie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, announced that a poster detailing the genetic basis for how its drug candidate NE3107 regulated specific genes in a manner significantly correlated with observed cognitive and biomarker improvements will be presented this weekend at the Alzheimer’s Associate’s International Conference (AAIC) to be held in Amsterdam July 16-20, 2023.
|
American Resources Corporation's ReElement Technologies Selects Location for Its Next Critical Mineral Refining Facility in Marion, Indiana
American Resources’ (Nasdaq: AREC) wholly owned subsidiary, ReElement Technologies LLC, a leading provider of high performance refining capacity of battery and rare earth elements, announced it has taken a controlling interest in the former RCA Thomson plant in Marion, Indiana, comprising 425,000 square feet manufacturing capacity on a 42 acre total campus for ReElement Technologies' rare earth and battery material refining.
|
|
|
Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation
Aridis (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) Designation under the Generating Antibiotic Incentives Now (GAIN) Act for AR-301, a fully human IgG1 monoclonal antibody (mAb) currently in Phase 3 clinical development as an adjunctive therapy for pneumonia caused by gram-positive Staphylococcus aureus in critically ill hospitalized patients.
|
BullFrog AI Announces Appointment of Enrique García-Rivera as Vice President of Artificial Intelligence
BullFrog AI (Nasdaq: BFRG), a precision medicine company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced the appointment of Enrique García-Rivera, Ph.D., as its new Vice President of Artificial Intelligence. The appointment will further advance BullFrog AI’s best-in-class proprietary bfLEAP™ AI platform that is engineered to enable more accurate predictions of patient disease progression and improve the design of clinical trials to speed safe and effective drug development.
|
|
|
Upcoming Events |
|
|
|
NASDAQ: SNGX - Soligenix |
4:15pm Eastern |
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
OTC: EBZT - Everything Blockchain |
4:15pm Eastern |
Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. |
|
|
|
|
NYSE American: GRFX - Graphex Group |
4:15pm Eastern |
Graphex Group is a global leader in the mid-stream deep processing of natural spherical graphite and graphene-related products, key components of the Lithium-ion (Li-ion) batteries used in Electric Vehicles (EVs), renewable energy storage systems, and other use cases. |
|
|
|
|
NASDAQ: STSS - Sharps Technology |
4:15pm Eastern |
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
Archive Events |
|
|
|
NASDAQ: BIVI - BioVie |
Meeting Duration 47 minutes |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
NASDAQ: SPI - SPI Energy |
Meeting Duration 33 minutes |
We are delighted to invite you to SPI Energy's Investor Day 2023, where you will have the chance to learn more about our strategic vision and growth plans and hear from key members of our leadership team. |
|
|
|
|
NASDAQ: BFRG - BullFrog AI |
Meeting Duration 31 minutes |
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
Meeting Duration 39 minutes |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
NASDAQ: ARDS - Aridis Pharmaceuticals |
Meeting Duration 48 minutes |
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
NASDAQ: RVSN - Rail Vision |
Meeting Duration 36 minutes |
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
|
|
NYSE American: GNS - Genius Group |
Meeting Duration 44 minutes |
Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
NASDAQ: STSS - Sharps Technology |
Meeting Duration 48 minutes |
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
NASDAQ: LTRN - Lantern Pharma |
Meeting Duration 34 minutes |
Lantern Pharma is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies. |
|
|
|
|
NASDAQ: SNGX - Soligenix |
Meeting Duration 48 minutes |
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
Lesson of the Week
Learn why getting in ahead of Wall Street analysts is key to your investing success.
|
|
|
MidSouth Week in Review
Inflation declined to 3% in June, its lowest level since 2021.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
© 2023 RedChip , All rights reserved
|
|
|
|
|